PAFAH1B3 and cancer: PAFAH1B3 is a critical metabolic enzyme in driving triple-negative breast carcinogenesis, and targeted suppression of PAFAH1B3 results in the upregulation of multiple oncogenic signaling pathways, which contributes to the inhibition of proliferation and invasive capacity of cancer cells, and may potentially serve as a novel therapeutic target [25].